Aubío Cold Sore Treatment launches at Target
BOCA RATON, Fla. — Florida-based Aubío Life Sciences, a new skin care company co-founded by U.S. businessman John Paul DeJoria, announced Monday that its flagship products Aubío Cold Sore Treatment Gel and Aubío Hydrating Lip Therapy are now available nationwide at Target stores and on target.com.
DeJoria, the major investor behind Aubío, is world renowned for his part in developing the extraordinarily successful plant-based products of Paul Mitchell and Patron Tequila.
"I've developed this company to make a tremendous difference in people's lives and spending millions on research, development, tests and clinical studies, and I knew personally that what we're seeing is unbelievable results with the science behind Aubío," DeJoria said.
Aubío for Cold Sore Treatment Gel highlights include:
- Proprietary advanced superbotanicals is a proprietary plant complex that facilitates delivery of key ingredients into the skin, in turn delivering ultra-effective relief of cold sore/fever blister symptoms
- Developed at major academic research center in the U.S.
- Natural proprietary core technology, plant-based formula
- Skin lipids to restore compromised lips
- Dermatologist developed
- Has undergone multiple safety and efficacy (performance) studies
WellCare of Georgia increases OTC, vision Medicaid benefits to boost preventative care
ATLANTA – WellCare of Georgia, a subsidiary of WellCare Health Plans, enhanced its Medicaid benefits Thursday by adding new incentives to its healthy rewards program and increasing its over-the-counter and vision program benefits.
The healthy rewards program incentivizes Georgia Medicaid members to complete specific preventive health, wellness and engagement milestones. The achievement of a healthy behavior earns the member a debit card with an amount up to $50, depending upon the type of healthy behavior completed. New to the program this year, members who meet their prescribed prenatal and postpartum visits will receive a $50 debit card plus their choice of a stroller, portable playpen or six packs of diapers.
"Preventive care is crucial to achieving and maintaining health," stated John Alexander Johnson, senior medical director for WellCare of Georgia. "We are committed to continually improving the care and services we provide to our members to help them stay healthy. The earlier we seek preventive care the better, which is why we work very hard to ensure expectant mothers get the care they need for their babies," he said. "Babies born to mothers who lack prenatal care have three times the chance of being born with low-birth weight. Our goal is for mothers to have healthy pregnancies and healthy babies."
WellCare of Georgia Medicaid members will also receive a 20% increase in their credit toward OTC supplies. Each Medicaid member will receive a $12 monthly allowance against an asssortment of more than 200 items, including vitamins, toothbrushes and cold remedies.
And the increased vision benefit includes a $50 credit towards eyeglasses, with additional frame options beyond what is covered by traditional Medicaid. An annual eye exam and eye care supplies, including OTC reading glasses, eyewashes and eye drops are also available at no cost to these members.
"Our enhanced benefits are designed to positively impact the health of our Georgia Medicaid members and ultimately can help to reduce the long-term costs of health care," said Roman Kulich, WellCare's region president, Georgia and South Carolina.
As of March 31, 2016, WellCare serves approximately 583,000 Medicaid and PeachCare for Kids plan members, 37,000 Medicare Advantage plan members and 24,000 Medicare Prescription Drug Plan members in Georgia.
FDA extends shelf life of Flublok influenza vaccine
MERIDEN, Conn. – Protein Sciences announced Thursday that FDA has extended the shelf life for Flublok, its seasonal influenza vaccine, to nine months from the date of manufacture. That increases the previous shelf life by three months. The longer shelf life will make it easier for healthcare providers and pharmacies to stock Flublok and vaccinate people throughout the influenza season, which in some years can last as long as April or May.
"We are pleased to add an extended shelf life to the list of product improvements we have been able to achieve for Flublok," stated Penny Post, Protein Sciences VP regulatory affairs. "We were first able to expand the approved age range for Flublok to everyone 18 years and older in October 2014. In addition to the nine month shelf life we just achieved, Flublok Quadrivalent is under review and FDA approval is anticipated this fall. We are working towards securing a one year shelf life as well."
In a clinical study of approximately 9,000 adults 50 years and older, Flublok proved to be 43% more effective than a traditional egg-based flu vaccine in protecting people against cell culture confirmed influenza, the company noted.